1Sutor AH, von Kries R, Comclissen EA, et al. Vitamin K deficency bleeding(VKDB) in infan[J]. Thromb Haemost, 1999,81(3):456-61.
2Roman E, Fear NT, Ansell P, et al. Vitamin K and childhood cancer, analysis of individual patient data from six case -control studies[J]. Br J Cancer, 2002,86(1):63-9.
3Parker L, Cole M, Croft AW, et al. Neonatal vitamin K administration and childhood cancvr in the north of England:retrospoctive case -control study[J]. BMJ, 1998,316(7126):189-93.
4Passmore SJ, Draper G, Bmwnbill P, et al. Case-control studies of relation betwen childhood cancer and neonatal vitamin K administration[J]. BMJ, 1998,316(7126):178-84.
5Kaplan M, Waisman D, Mazor D, et al. Effect of vitamin k1 on glucose-6-phosphate dehydaagenase defident neonatal erythrocytes in vitro[J]. Arch Dis Child Fetal Neonatal Ed, 1998,79(3):F218-20.
6Autret-Leca E, Jonville-Beta AP. Vitamin K in neonates: how to administer, when and to whom[J]. Paediatr Drugs, 2001,3(1):1-8.
7von Kries R, Hachmeister A, Gobel U. Can 3 oral 2 mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding?[J]. Eur J Pediatr. 1999,158(Suppl 3):S183-6.
8Gteer FR, Marshall SP, Scverson RR, et al. A new mixed micelliar preparation for oral vitamin K prophylaxis: randomized controlled comparison with an intramuscular formulation in breast fed infants[J].Arch Dis Child, 1998,79(4):300-5.
9Schubiger G, Stocker C, Banfiger O, et al. Oral vitamin K1 pvaphylaxis for nev/ooms with a new mixed -micdlar perparation of phylloquinone: 3 years experience in Switerland[J]Eur J Pediatr,1999,158(7):599- 602.
10Nishiguchi T, Matsuyama K, Kobayashi T, et al. Variation of desgamma-carboxypm-thrombin (PIVKA-Ⅱ） levels in cord blood throughout gestation[J]. Semin Thromb Heax~ost, 2001,27(2):87-92.
